by admin | Mar 12, 2023 | Uncategorized
Identification of Early Cancer through Peripheral Blood Mature Red Blood Cells! Chinese Scholars Reveal Cancer-Related Large DNA Fragments within Red Blood Cells for the First Time January 12, 2023 Liquid biopsy technology is the new direction for early screening and...
by admin | Dec 1, 2021 | Uncategorized
MBMbio announced residency at JLABS @ Shanghai December 1, 2021 Shanghai China, December 1, 2021 – MBMbio announced today that, effective December 1, 2021, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’). The company is...
by admin | Feb 5, 2021 | Uncategorized
The Often Neglected Red Blood Cell Offers a Breakthrough in Liquid Biopsy Technology for Early Stage Cancer Detection February 5, 2021 Liquid Biopsy Bottleneck Liquid biopsy can capture tumor-related information from the blood. With the advantages of high sample...
by admin | Dec 16, 2020 | Uncategorized
Colorectal Cancer Recurrence Risk Assessment Marker announced at the National Colorectal Surgery Symposium December 16, 2020 The 15th (2020) National Colorectal Surgery New Technology Seminar and Hunan Provincial Medical Association Surgery Professional Committee...
by admin | Nov 9, 2020 | Uncategorized
MBM recognized as a Top 30 enterprise in the 2020 National Innovation & Entrepreneurship Competition November 9, 2020 MBM’s “Artificial Intelligence Digital Pathology Analysis System for Tumor diagnostic” was unveiled in the finals of the Ninth...
Recent Comments